Security National Bank Bristol Myers Squibb CO Transaction History

Security National Bank

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 15, 2018	SELL	$55.19 - $62.25 $2.8 Million - $3.16 Million	-50,815 Closed	0 $0
Q2 2018 Jul 26, 2018	BUY	$50.53 - $62.98 $152,701 - $190,325	3,022 Added 6.32%	50,815 $2.81 Million
Q1 2018 May 09, 2018	SELL	$59.92 - $68.98 $68,368 - $78,706	-1,141 Reduced 2.33%	47,793 $3.02 Million
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $8,991 - $9,802	-150 Reduced 0.31%	48,934 $3 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $47,111 - $54,370	853 Added 1.77%	49,084 $3.13 Million
Q2 2017 Jan 03, 2018	BUY	N/A	1,967 Added 4.25%	48,231 $2.69 Million
Q1 2017 Jan 04, 2018	BUY	N/A	46,264	46,264 $2.52 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Security National Bank, based on Form 13F filings with the SEC.

Stay updated on Security National Bank with notifications on news.